211 related articles for article (PubMed ID: 37140480)
1. Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies.
Rayman JB
Expert Opin Ther Targets; 2023; 27(4-5):269-279. PubMed ID: 37140480
[TBL] [Abstract][Full Text] [Related]
2. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
Langerscheidt F; Wied T; Al Kabbani MA; van Eimeren T; Wunderlich G; Zempel H
J Neurol; 2024 Jun; 271(6):2992-3018. PubMed ID: 38554150
[TBL] [Abstract][Full Text] [Related]
3. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
4. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
[TBL] [Abstract][Full Text] [Related]
5. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
[TBL] [Abstract][Full Text] [Related]
6. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
[TBL] [Abstract][Full Text] [Related]
8. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
[TBL] [Abstract][Full Text] [Related]
9. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
[TBL] [Abstract][Full Text] [Related]
10. Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.
Pasinetti GM; Ksiezak-Reding H; Santa-Maria I; Wang J; Ho L
J Neurochem; 2010 Sep; 114(6):1557-68. PubMed ID: 20569300
[TBL] [Abstract][Full Text] [Related]
11. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.
Villemagne VL; Okamura N
Curr Opin Neurobiol; 2016 Feb; 36():43-51. PubMed ID: 26397020
[TBL] [Abstract][Full Text] [Related]
12. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
[TBL] [Abstract][Full Text] [Related]
13. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
[TBL] [Abstract][Full Text] [Related]
14. Targeting tau: Clinical trials and novel therapeutic approaches.
VandeVrede L; Boxer AL; Polydoro M
Neurosci Lett; 2020 Jul; 731():134919. PubMed ID: 32380145
[TBL] [Abstract][Full Text] [Related]
15.
Liu FT; Lu JY; Li XY; Jiao FY; Chen MJ; Yao RX; Liang XN; Ju ZZ; Ge JJ; Li G; Shen B; Wu P; Song J; Li J; Sun YM; Wu JJ; Yen TC; Luo JF; Zhao QH; Zuo C; Wang J;
Mov Disord; 2023 Apr; 38(4):579-588. PubMed ID: 36750757
[TBL] [Abstract][Full Text] [Related]
16. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
17. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
18. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.
Khanna MR; Kovalevich J; Lee VM; Trojanowski JQ; Brunden KR
Alzheimers Dement; 2016 Oct; 12(10):1051-1065. PubMed ID: 27751442
[TBL] [Abstract][Full Text] [Related]
20. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]